Biologics Safety Testing Market Size, Share Global Analysis Report, 2020–2026

Industry Insights

The biologics safety testing market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire biologics safety testing market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

This specialized and expertise-oriented industry research report scrutinizes the technical and commercial business outlook of the biologics safety testing industry. The report analyzes and declares the historical and current trends analysis of the biologics safety testing industry and subsequently recommends the projected trends anticipated to be observed in the biologics safety testing market during the upcoming years.

Key Insights from Primary Research

• According to the primary CXOs of the global biologics safety testing market, the market is estimated to witness a substantial growth of nearly 11 % over the forecast period.
• The market was valued at USD 3.0 Billion, in 2019 and is expected to be valued at over USD 6.8 Billion.
• Asia Pacific market is expected to be the fastest goring region for biologics safety testing over the forecast period owing to growing investments for R&D in the region.
• By geography, the North American region headed the market with the highest share in 2019.

Key Recommendations from Analysts

• The strategic developments such as regional expansion, product innovations, and ongoing research and developments by the major companies such as Merck KGaA, Charles River Laboratories, Lonza Group LTD., and Toxikon Corporation is likely to boom the market’s growth over the upcoming years.
• Our analysts recommend that the Asia Pacific region is predicted to witness significant growth.
• On the basis of the product type segment, Reagents and Kits dominated the global biologics safety testing market in 2019. In terms of revenue, it accounted for a significant share of the total market in 2019.
• Strengthening the distribution channel may also help the major player to cater to the lucrative growth of the market over the years to come.

Market Share Analysis by Product

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the biologics safety testing industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the biologics safety testing industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the biologics safety testing market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the biologics safety testing industry. The biologics safety testing market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the biologics safety testing sector. Key strategic developments in the biologics safety testing market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the biologics safety testing market are appropriately highlighted in the report.

The biologics safety testing market research report delivers an acute valuation and taxonomy of the biologics safety testing industry by practically splitting the market on the basis of different types, categories, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the biologics safety testing industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the biologics safety testing industry is provided for the leading economies of the world.

Biologics products are added to products derived from biological sources. Biologics are used in animals and humans as medical devices. Demand for the biologics safety testing market is driven by growing demand for biologics to tackle the burden of various chronic diseases, increased investment in life science research and development, rapid growth in new product launches, growth in pharmaceutical and biopharmaceutical research, and increased prevalence of chronic disorders.

The global biologics safety testing market has been segmented on the basis of product, test type, and application. On the basis of product segment, the target market is segmented into reagents and kits, services, and instruments. Also, on the basis of test type segment the global market is segmented into endotoxin tests, sterility tests, cell line authentication and characterization tests, residual host contamination detection tests, adventitious agent detection tests, bioburden tests, and other tests.

Report Scope

Some of the essential players operating in the biologics safety testing market, but not restricted to include:

•  Merck KGaA
•  Pace Analytical Services Inc.
•  Charles River Laboratories
•  Toxikon Corporation
•  Cytovance Biologics Inc.
•  Sartorius AG
•  Thermo Fisher Scientific Inc.
•  WuXi Apptec
•  SGS SA
• Lonza Group LTD.

The taxonomy of the biologics safety testing industry by its scope and segmentation is as follows:

By Product

• Reagents and Kits
• Services
• Instruments

By Test Type

• Endotoxin Tests
• Sterility Tests
• Cell Line Authentication and Characterization Tests
• Residual Host Contamination Detection Tests
• Adventitious Agent Detection Tests
• Bioburden tests
• Other Tests

By Application

• Vaccine and Therapeutics Development
• Blood and Blood-related Products Testing
• Cellular and Gene Therapy
• Tissue and Tissue-related Products Testing
• Stem Cell Research

Regional Segmentation Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa